ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)
Japan · Delayed Price · Currency is JPY 2,136.00
-18.00 (-0.84%)
Aug 25, 2026, 3:30 PM JST
TYO:4886 Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 70,870 | 71,127 | 64,139 | 62,843 | 60,461 | 56,607 |
Revenue Growth | 5.61% | 10.90% | 2.06% | 3.94% | 6.81% | 2.58% |
Gross Profit Gross Profit Growth | 33,605 | 34,145 | 31,336 | 30,665 | 28,585 | 26,352 |
Operating Income Operating Income Growth | 5,081 | 5,834 | 5,333 | 6,501 | 5,109 | 4,796 |
Net Income Net Income Growth | 4,702 | 5,424 | 5,101 | 7,545 | 4,238 | 4,290 |
Earnings Per Share EPS Growth | 165.62 | 191.10 | 179.95 | 266.49 | 150.08 | 151.22 |
EPS Growth | -7.41% | 6.20% | -32.47% | 77.57% | -0.75% | 58.03% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Unallocated Adjustment Unallocated Adjustment Growth | -80 | -81 | -88 | -64 | -77 | -73 |
Pharmaceuticals Business Pharmaceuticals Business Growth | 58,896 | 58,927 | 56,655 | 56,016 | 53,579 | 50,791 |
Overseas Business Overseas Business Growth | 4,322 | 4,640 | - | - | - | - |
Animal Health Business Animal Health Business Growth | 7,445 | 7,334 | 7,246 | 6,664 | 6,660 | - |
Other Other Growth | 284 | 306 | 325 | 226 | 298 | 5,890 |
Total Total Growth | 70,867 | 71,126 | 64,138 | 62,842 | 60,460 | 56,608 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 7,108 | 11,019 | 11,158 | 17,238 | 17,905 | 17,103 |
Total Debt Total Debt Growth | 11,835 | 11,434 | 10,902 | 9,485 | 12,623 | 14,046 |
Net Cash (Debt) Net Cash Growth | -4,727 | -415 | 256 | 7,753 | 5,282 | 3,057 |
Net Cash Growth | - | - | -96.70% | 46.78% | 72.78% | - |
Net Cash Per Share Net Cash Per Share Growth | -166.47 | -14.62 | 9.03 | 273.83 | 187.05 | 107.75 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 6,303 | 2,485 | 1,486 | 3,351 | 2,842 |
Capital Expenditures CapEx Growth | - | -2,549 | -2,960 | -1,320 | -461 | -579 |
Free Cash Flow Free Cash Flow Growth | - | 3,754 | -475 | 166 | 2,890 | 2,263 |
Free Cash Flow Growth | - | - | - | -94.26% | 27.71% | -58.38% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | - | 48.01% | 48.86% | 48.80% | 47.28% | 46.55% |
Operating Margin | 7.17% | 8.20% | 8.31% | 10.35% | 8.45% | 8.47% |
Pretax Margin | 8.63% | 9.83% | 9.65% | 15.69% | 8.86% | 10.89% |
Profit Margin | 6.64% | 7.63% | 7.95% | 12.01% | 7.01% | 7.58% |
FCF Margin | - | 5.28% | -0.74% | 0.26% | 4.78% | 4.00% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 65.000 | 60.000 | 55.000 | 40.000 | 16.000 | 15.000 |
Dividend Per Share Growth | 14.04% | 9.09% | 37.50% | 150.00% | 6.67% | - |
Dividend Yield | 2.97% | 2.54% | 2.45% | 1.89% | 1.44% | 1.29% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.01 | 12.36 | 12.81 | 8.33 | 7.93 | 8.32 |
Forward PE | 12.53 | 12.16 | 12.36 | 12.20 | 7.39 | 9.51 |
P/FCF Ratio | 16.29 | 17.85 | - | 378.69 | 11.63 | 15.76 |
PS Ratio | 0.86 | 0.94 | 1.02 | 1.00 | 0.56 | 0.63 |